{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T11:17:13Z","timestamp":1774869433275,"version":"3.50.1"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.bbr.2013.01.011","type":"journal-article","created":{"date-parts":[[2013,1,17]],"date-time":"2013-01-17T15:51:54Z","timestamp":1358437914000},"page":"205-212","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Nasal inoculation with \u03b1-synuclein aggregates evokes rigidity, locomotor deficits and immunity to such misfolded species as well as dopamine"],"prefix":"10.1016","volume":"243","author":[{"given":"Marina A.","family":"Gruden","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatiana V.","family":"Davidova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiran","family":"Yanamandra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valery G.","family":"Kucheryanu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludmilla A.","family":"Morozova-Roche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladimir V.","family":"Sherstnev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert D.E.","family":"Sewell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2013.01.011_bib0005","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1016\/j.febslet.2009.06.030","article-title":"Bridging the gap: from protein misfolding to protein misfolding diseases","volume":"583","author":"Luheshi","year":"2009","journal-title":"FEBS Letters"},{"issue":"5","key":"10.1016\/j.bbr.2013.01.011_bib0010","doi-asserted-by":"crossref","first-page":"e1001335","DOI":"10.1371\/journal.pbio.1001335","article-title":"Common features at the start of the neurodegeneration cascade","volume":"10","author":"Herv\u00e1s","year":"2012","journal-title":"PLoS Biology"},{"issue":"5646","key":"10.1016\/j.bbr.2013.01.011_bib0015","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1087753","article-title":"Molecular pathways of neurodegeneration in Parkinson's disease","volume":"302","author":"Dawson","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.bbr.2013.01.011_bib0020","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2174\/138920308785915218","article-title":"Alpha-synuclein misfolding and neurodegenerative diseases","volume":"9","author":"Uversky","year":"2008","journal-title":"Current Protein and Peptide Science"},{"key":"10.1016\/j.bbr.2013.01.011_bib0025","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/01720610-201205000-00017","article-title":"Parkinson disease","volume":"25","author":"Park","year":"2012","journal-title":"Journal of the American Academy of Physician Assistants"},{"key":"10.1016\/j.bbr.2013.01.011_bib0030","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1110\/ps.073181508","article-title":"Molecular determinants of the aggregation behavior of alpha- and beta-synuclein","volume":"17","author":"Rivers","year":"2008","journal-title":"Protein Science"},{"key":"10.1016\/j.bbr.2013.01.011_bib0035","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.bbapap.2010.01.017","article-title":"Understanding protein non-folding","volume":"1804","author":"Uversky","year":"2010","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.bbr.2013.01.011_bib0040","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/978-1-61779-968-6_34","article-title":"Nanobodies as structural probes of protein misfolding and fibril formation","volume":"911","author":"De Genst","year":"2012","journal-title":"Methods in Molecular Biology"},{"key":"10.1016\/j.bbr.2013.01.011_bib0045","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/syn.20456","article-title":"Behavioral and histopathological consequences of paraquat intoxication in mice: effects of alpha-synuclein over-expression","volume":"61","author":"Fernagut","year":"2007","journal-title":"Synapse"},{"key":"10.1016\/j.bbr.2013.01.011_bib0050","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1756-6606-3-35","article-title":"Nigrostriatal neuronal death following chronic dichlorvos exposure: crosstalk between mitochondrial impairments, \u03b1-synuclein aggregation, oxidative damage and behavioral changes","volume":"3","author":"Binukumar","year":"2010","journal-title":"Molecular Brain"},{"key":"10.1016\/j.bbr.2013.01.011_bib0055","doi-asserted-by":"crossref","first-page":"489","DOI":"10.2174\/138161211795164095","article-title":"The intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a new rodent model to test palliative and neuroprotective agents for Parkinson's disease","volume":"17","author":"Prediger","year":"2011","journal-title":"Current Pharmaceutical Design"},{"key":"10.1016\/j.bbr.2013.01.011_bib0060","doi-asserted-by":"crossref","first-page":"482","DOI":"10.2174\/187152710791556177","article-title":"alpha-Synuclein- and MPTP-generated rodent models of Parkinson's disease and the study of extracellular striatal dopamine dynamics: a microdialysis approach","volume":"9","author":"Bazzu","year":"2010","journal-title":"CNS & Neurological Disorders Drug Targets"},{"key":"10.1016\/j.bbr.2013.01.011_bib0065","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.nbd.2005.12.003","article-title":"Intersecting pathways to neurodegeneration in Parkinson's disease: effects of the pesticide rotenone on DJ-1, alpha-synuclein, and the ubiquitin-proteasome system","volume":"22","author":"Betarbet","year":"2006","journal-title":"Neurobiology of Disease"},{"issue":"7","key":"10.1016\/j.bbr.2013.01.011_bib0070","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1111\/j.1742-4658.2012.08491.x","article-title":"Animal models of Parkinson's disease","volume":"279","author":"Blandini","year":"2012","journal-title":"FEBS Journal"},{"key":"10.1016\/j.bbr.2013.01.011_bib0075","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s007020100004","article-title":"Neurochemical findings in the MPTP model of Parkinson's disease","volume":"108","author":"Schmidt","year":"2001","journal-title":"Journal of Neural Transmission"},{"key":"10.1016\/j.bbr.2013.01.011_bib0080","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s12640-009-9061-x","article-title":"Progressive dopaminergic degeneration in the chronic MPTP mouse model of Parkinson's disease","volume":"16","author":"Schintu","year":"2009","journal-title":"Neurotoxicity Research"},{"issue":"Suppl. 2","key":"10.1016\/j.bbr.2013.01.011_bib0085","first-page":"S16","article-title":"Functional models of Parkinson's disease: a valuable tool in the development of novel therapies","volume":"64","author":"Jenner","year":"2008","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.bbr.2013.01.011_bib0090","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0014-2999(84)90221-8","article-title":"Neurochemical and behavioral effects of systemic and intranigral administration of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the rat","volume":"100","author":"Chiueh","year":"1984","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.bbr.2013.01.011_bib0095","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1073\/pnas.84.10.3521","article-title":"Correlation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity with blood\u2013brain barrier monoamine oxidase activity","volume":"84","author":"Kalaria","year":"1987","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/j.bbr.2013.01.011_bib0100","first-page":"1000","article-title":"Studies on species sensitivity to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Part 1: systemic administration","volume":"270","author":"Giovanni","year":"1994","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.bbr.2013.01.011_bib0105","first-page":"669","article-title":"On the mechanisms underlying 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity: the effect of perinigral infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, its metabolite and their analogs in the rat","volume":"241","author":"Harik","year":"1987","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.bbr.2013.01.011_bib0110","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0166-4328(01)00211-X","article-title":"Memory disruption in rats with nigral lesions induced by MPTP: a model for early Parkinson's disease amnesia","volume":"124","author":"Da Cunha","year":"2001","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/j.bbr.2013.01.011_bib0115","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1023\/A:1020736131907","article-title":"The lesion of the rat substantia nigra pars compacta dopaminergic neurons as a model for Parkinson's Disease memory disabilities","volume":"22","author":"Da Cunha","year":"2002","journal-title":"Cellular and Molecular Neurobiology"},{"key":"10.1016\/j.bbr.2013.01.011_bib0120","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jneumeth.2005.04.005","article-title":"Comparison of bilaterally 6-OHDA- and MPTP-lesioned rats as models of the early phase of Parkinson's disease: histological, neurochemical, motor and memory alterations","volume":"148","author":"Ferro","year":"2005","journal-title":"Journal of Neuroscience Methods"},{"key":"10.1016\/j.bbr.2013.01.011_bib0125","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.expneurol.2006.07.001","article-title":"The risk is in the air: intranasal administration of MPTP to rats reproducing clinical features of Parkinson's disease","volume":"202","author":"Prediger","year":"2006","journal-title":"Experimental Neurology"},{"key":"10.1016\/j.bbr.2013.01.011_bib0130","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1749-6632.2009.03885.x","article-title":"Risk is in the air: an intranasal MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) rat model of Parkinson's disease","volume":"1170","author":"Prediger","year":"2009","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.bbr.2013.01.011_bib0135","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s00702-010-0464-x","article-title":"Proanthocyanidin-rich fraction from Croton celtidifolius Baill confers neuroprotection in the intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine rat model of Parkinson's disease","volume":"117","author":"Moreira","year":"2010","journal-title":"Journal of Neural Transmission"},{"key":"10.1016\/j.bbr.2013.01.011_bib0140","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.bbr.2012.01.016","article-title":"Lithium and valproate prevent olfactory discrimination and short-term memory impairments in the intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) rat model of Parkinson's disease","volume":"229","author":"Castro","year":"2012","journal-title":"Behavioural Brain Research"},{"issue":"4","key":"10.1016\/j.bbr.2013.01.011_bib0145","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/j.1471-4159.2012.07805.x","article-title":"Potential role of \u03b1-synuclein in neurodegeneration: studies in a rat animal model","volume":"122","author":"Stoica","year":"2012","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.bbr.2013.01.011_bib0150","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.molbrainres.2004.09.017","article-title":"The MPTP model of Parkinson's disease","volume":"134","author":"Smeyne","year":"2005","journal-title":"Brain Research. Molecular Brain Research"},{"key":"10.1016\/j.bbr.2013.01.011_bib0155","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0378-4274(90)90192-O","article-title":"Tissue concentrations of MPTP and MPP+ after administration of lethal and sublethal doses of MPTP to mice","volume":"54","author":"Fuller","year":"1990","journal-title":"Toxicology Letters"},{"issue":"1","key":"10.1016\/j.bbr.2013.01.011_bib0160","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.expneurol.2012.02.012","article-title":"Comparison of the behavioural and histological characteristics of the 6-OHDA and alpha-synuclein rat models of Parkinson's disease","volume":"235","author":"Decressac","year":"2012","journal-title":"Experimental Neurology"},{"key":"10.1016\/j.bbr.2013.01.011_bib0165","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.nbd.2011.12.013","article-title":"Progressive neurodegenerative and behavioural changes induced by AAV-mediated over-expression of alpha-synuclein in midbrain dopamine neurons","volume":"45","author":"Decressac","year":"2012","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.bbr.2013.01.011_bib0170","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.expneurol.2012.05.022","article-title":"Do alpha-synuclein vector injections provide a better model of Parkinson's disease than the classic 6-hydroxydopamine model","volume":"237","author":"Lindgren","year":"2012","journal-title":"Experimental Neurology"},{"key":"10.1016\/j.bbr.2013.01.011_bib0175","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1111\/j.1460-9568.2006.05060.x","article-title":"Persistent penetration of MPTP through the nasal route induces Parkinson's disease in mice","volume":"24","author":"Rojo","year":"2006","journal-title":"European Journal of Neuroscience"},{"key":"10.1016\/j.bbr.2013.01.011_bib0180","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s12640-011-9281-8","article-title":"Intranasal administration of neurotoxicants in animals: support for the olfactory vector hypothesis of Parkinson's disease","volume":"21","author":"Prediger","year":"2012","journal-title":"Neurotoxicity Research"},{"key":"10.1016\/j.bbr.2013.01.011_bib0185","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1093\/brain\/awh625","article-title":"A possible role for humoral immunity in the pathogenesis of Parkinson's disease","volume":"128","author":"Orr","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.bbr.2013.01.011_bib0190","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1111\/j.1582-4934.2008.00450.x","article-title":"Immunological features of alpha-synuclein in Parkinson's disease","volume":"12","author":"Roodveldt","year":"2008","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"10.1016\/j.bbr.2013.01.011_bib0195","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jneuroim.2010.12.001","article-title":"Immunoprotection against toxic biomarkers is retained during Parkinson's disease progression","volume":"233","author":"Gruden","year":"2011","journal-title":"Journal of Neuroimmunology"},{"issue":"6","key":"10.1016\/j.bbr.2013.01.011_bib0200","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1159\/000341400","article-title":"Correlation between protective immunity to \u03b1-synuclein aggregates, oxidative stress and inflammation","volume":"19","author":"Gruden","year":"2012","journal-title":"Neuroimmunomodulation"},{"issue":"4","key":"10.1016\/j.bbr.2013.01.011_bib0205","doi-asserted-by":"crossref","first-page":"e18513","DOI":"10.1371\/journal.pone.0018513","article-title":"\u03b1-Synuclein reactive antibodies as diagnostic biomarkers in blood sera of Parkinson's disease patients","volume":"6","author":"Yanamandra","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bbr.2013.01.011_bib0210","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nprot.2006.342","article-title":"Protocol for the MPTP mouse model of Parkinson's disease","volume":"2","author":"Jackson-Lewis","year":"2007","journal-title":"Nature Protocols"},{"key":"10.1016\/j.bbr.2013.01.011_bib0215","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0166-4328(01)00309-6","article-title":"Behavioral phenotyping of the MPTP mouse model of Parkinson's disease","volume":"125","author":"Sedelis","year":"2001","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/j.bbr.2013.01.011_bib0220","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1006\/exnr.2002.8021","article-title":"Detection of behavioural impairments correlated to neurochemical deficits in mice treated with moderate doses of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"178","author":"Tillerson","year":"2002","journal-title":"Experimental Neurology"},{"key":"10.1016\/j.bbr.2013.01.011_bib0225","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.neuroscience.2011.03.007","article-title":"Modeling of presymptomatic and symptomatic stages of parkinsonism in mice","volume":"181","author":"Ugrumov","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2013.01.011_bib0230","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0928-4680(96)00160-5","article-title":"Effects of fibroblast growth factors on MPTP-induced parkinsonian syndrome in mice","volume":"4","author":"Kryzhanovsky","year":"1997","journal-title":"Pathophysiology"},{"key":"10.1016\/j.bbr.2013.01.011_bib0235","first-page":"219","article-title":"Some observations on the effects of two enantiomers of two benzomorphan narcotic antagonists and atropine on analgesia, tremor and hypothermia produced by oxotremorine","volume":"256","author":"Ben-Sreti","year":"1982","journal-title":"Archives Internationales de Pharmacodynamie et de Therapie"},{"key":"10.1016\/j.bbr.2013.01.011_bib0240","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/3311","article-title":"Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease","volume":"4","author":"Conway","year":"1998","journal-title":"Nature Medicine"},{"key":"10.1016\/j.bbr.2013.01.011_bib0245","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0022-2836(02)00775-1","article-title":"Dependence of alpha-synuclein aggregate morphology on solution conditions","volume":"322","author":"Hoyer","year":"2002","journal-title":"Journal of Molecular Biology"},{"key":"10.1016\/j.bbr.2013.01.011_bib0250","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1006\/jsbi.2000.4264","article-title":"Amyloid fibril formation and seeding by wild-type human lysozyme and its disease-related mutational variants","volume":"130","author":"Morozova-Roche","year":"2000","journal-title":"Journal of Structural Biology"},{"key":"10.1016\/j.bbr.2013.01.011_bib0255","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/pro.5560020312","article-title":"Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution","volume":"2","author":"LeVine","year":"1993","journal-title":"Protein Science"},{"key":"10.1016\/j.bbr.2013.01.011_bib0260","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S0022-2836(03)00551-5","article-title":"Amyloid protofilaments from the calcium-binding protein equine lysozyme: formation of ring and linear structures depends on pH and metal ion concentration","volume":"330","author":"Malisauskas","year":"2003","journal-title":"Journal of Molecular Biology"},{"key":"10.1016\/j.bbr.2013.01.011_bib0265","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jneuroim.2007.03.023","article-title":"Differential neuroimmune markers to the onset of Alzheimer's disease neurodegeneration and dementia: autoantibodies to Abeta (25\u201335) oligomers, S100b and neurotransmitters","volume":"186","author":"Gruden","year":"2007","journal-title":"Journal of Neuroimmunology"},{"issue":"6","key":"10.1016\/j.bbr.2013.01.011_bib0270","doi-asserted-by":"crossref","first-page":"e38545","DOI":"10.1371\/journal.pone.0038545","article-title":"The role of alpha-synuclein oligomerization and aggregation in cellular and animal models of Parkinson's disease","volume":"7","author":"Wan","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bbr.2013.01.011_bib0275","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1093\/brain\/awn349","article-title":"Detection of elevated levels of soluble alpha-synuclein oligomers in post-mortem brain extracts from patients with dementia with Lewy bodies","volume":"132","author":"Paleologou","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.bbr.2013.01.011_bib0280","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1212\/WNL.0b013e3181fd613b","article-title":"Detection of elevated levels of \u03b1-synuclein oligomers in CSF from patients with Parkinson disease","volume":"75","author":"Tokuda","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.bbr.2013.01.011_bib0285","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1073\/pnas.0407146102","article-title":"Release of long-range tertiary interactions potentiates aggregation of natively unstructured alpha-synuclein","volume":"102","author":"Bertoncini","year":"2005","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/j.bbr.2013.01.011_bib0290","series-title":"Protein Misfolding in Neurodegenerative Diseases. Mechanisms and therapeutic strategies","first-page":"381","article-title":"Parkinson's disease: What is it? What causes it? And how can it be cured","author":"Foltynie","year":"2008"},{"issue":"3","key":"10.1016\/j.bbr.2013.01.011_bib0295","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1042\/BJ20111924","article-title":"Toxic prefibrillar \u03b1-synuclein amyloid oligomers adopt a distinctive antiparallel \u03b2-sheet structure","volume":"443","author":"Celej","year":"2012","journal-title":"Biochemical Journal"},{"issue":"5","key":"10.1016\/j.bbr.2013.01.011_bib0300","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.molmed.2012.03.002","article-title":"\u03b1-synuclein transfer: pathology propagation in Parkinson's disease","volume":"18","author":"Hansen","year":"2012","journal-title":"Trends in Molecular Medicine"},{"issue":"10","key":"10.1016\/j.bbr.2013.01.011_bib0305","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1523\/JNEUROSCI.5368-11.2012","article-title":"Accumulation of toxic \u03b1-synuclein oligomer within endoplasmic reticulum occurs in \u03b1-synucleinopathy in vivo","volume":"32","author":"Colla","year":"2012","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.bbr.2013.01.011_bib0310","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1111\/j.1742-4658.2012.08489.x","article-title":"Role of \u03b1-synuclein penetration into the membrane in the mechanisms of oligomer pore formation","volume":"279","author":"Tsigelny","year":"2012","journal-title":"FEBS Journal"},{"issue":"1","key":"10.1016\/j.bbr.2013.01.011_bib0315","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1039\/C1MB05293D","article-title":"Kinetic measurements give new insights into lipid membrane permeabilization by \u03b1-synuclein oligomers","volume":"8","author":"St\u00f6ckl","year":"2012","journal-title":"Molecular Biosystems"},{"key":"10.1016\/j.bbr.2013.01.011_bib0320","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/0748233710362382","article-title":"Environmental toxins and Parkinson's disease: putative roles of impaired electron transport chain and oxidative stress","volume":"26","author":"Arif","year":"2010","journal-title":"Toxicology and Industrial Health"},{"key":"10.1016\/j.bbr.2013.01.011_bib0325","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1006\/viro.1993.1248","article-title":"The olfactory nerve and not the trigeminal nerve is the major site of CNS entry for mouse hepatitis virus, strain JHM","volume":"194","author":"Barnett","year":"1993","journal-title":"Virology"},{"key":"10.1016\/j.bbr.2013.01.011_bib0330","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0006-8993(74)90476-4","article-title":"An autoradiographic investigation of the projection of the vomeronasal organ to the accessory olfactory bulb in the mouse","volume":"81","author":"Barber","year":"1974","journal-title":"Brain Research"},{"key":"10.1016\/j.bbr.2013.01.011_bib0335","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1523\/JNEUROSCI.23-01-00317.2003","article-title":"Olfactory signal transduction in the mouse septal organ","volume":"23","author":"Ma","year":"2003","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.bbr.2013.01.011_bib0340","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1111\/j.1460-9568.2006.04818.x","article-title":"Projection of the Gr\u00fcneberg ganglion to the mouse olfactory bulb","volume":"23","author":"Roppolo","year":"2006","journal-title":"European Journal of Neuroscience"},{"key":"10.1016\/j.bbr.2013.01.011_bib0345","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/ana.21327","article-title":"The olfactory vector hypothesis of neurodegenerative disease: is it viable?","volume":"63","author":"Doty","year":"2008","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.bbr.2013.01.011_bib0350","doi-asserted-by":"crossref","first-page":"20051","DOI":"10.1073\/pnas.0908005106","article-title":"\u03b1-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells","volume":"106","author":"Luk","year":"2009","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"2","key":"10.1016\/j.bbr.2013.01.011_bib0355","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.bbr.2012.08.017","article-title":"Neuroprotective effects of agmatine in mice infused with a single intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)","volume":"235","author":"Matheus","year":"2012","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/j.bbr.2013.01.011_bib0360","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.cell.2012.03.037","article-title":"Direct observation of the interconversion of normal and toxic forms of \u03b1-synuclein","volume":"149","author":"Cremades","year":"2012","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.bbr.2013.01.011_bib0365","doi-asserted-by":"crossref","first-page":"e27230","DOI":"10.1371\/journal.pone.0027230","article-title":"Antibodies against alpha-synuclein reduce oligomerization in living cells","volume":"6","author":"N\u00e4sstr\u00f6m","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bbr.2013.01.011_bib0370","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1021\/bi036281f","article-title":"Inhibiting asggregation of alpha-synuclein with human single chain antibody fragments","volume":"43","author":"Emadi","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbr.2013.01.011_bib0375","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.jmb.2007.02.089","article-title":"Isolation of a human single chain antibody fragment against oligomeric alpha-synuclein that inhibits aggregation and prevents alpha-synuclein induced toxicity","volume":"368","author":"Emadi","year":"2007","journal-title":"Journal of Molecular Biology"},{"key":"10.1016\/j.bbr.2013.01.011_bib0380","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/j.1471-4159.2004.02423.x","article-title":"Could a loss of alpha-synuclein function put dopaminergic neurons at risk","volume":"89","author":"Perez","year":"2004","journal-title":"Journal of Neurochemistry"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432813000211?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432813000211?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T12:29:46Z","timestamp":1595248186000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432813000211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":76,"alternative-id":["S0166432813000211"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2013.01.011","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}